Jiangsu Bioperfectus Technologies Co. Ltd.SSE: 688399

(688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Resolutions of the 18th Meeting of the 3rd Board of Directors

· Issued by Jiangsu Bioperfectus Technologies Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688399 · · 3 pages · Chinese

Summary by 6ix AI

The board reviewed a proposal to convene an extraordinary shareholders' meeting, which was ultimately not approved. Several directors expressed significant concerns regarding the validity of the controlling shareholder's documents and ongoing legal issues that could impact the company's governance. The announcement includes risk warnings related to the controlling shareholder's litigation status and potential changes in control.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688399jiangsu-bioperfectus-technologies-co-ltdannouncement-on-resolutions-of-the-18th-meeting-of-the-3rd-board-of-directors

本次董事会审议的议案未获通过。 一、董事会会议召开情况 江苏硕世生物科技股份有限公司（以下简称“公司”）第三届董事会第十八次会议于2026年10月2日以通讯方式召开。会议通知已于2026年9月27日以电子邮件方式送达全体董事。本次会议应出席董事9名，实际出席董事9名，会议由董事长王国强先生召集并主持。本次会议的召集、召开符合《中华人民共和国公司法》（以下简称“《公司法》”）等法律法规及《江苏硕世生物科技股份有限公司章程》（以下简称“《公司章程》”）的有关规定，会议合法有效。 二、董事会会议审议情况 审议《关于同意控股股东提请召开临时股东会的议案》 公司于 2026 年 9 月 22 日收到控股股东绍兴闰康生物医药股权投资合伙企业（有限合伙）（以下简称“闰康生物”）发来的《关于提请召开江苏硕世生物科技股份有限公司临时股东会的函》（以下简称“《提请函》”），具体内容详见公司于 2026 年 9

Jiangsu Bioperfectus Technologies Co. Ltd. on 6ix

Story so far

Earlier from Jiangsu Bioperfectus Technologies

Later from Jiangsu Bioperfectus Technologies

All Jiangsu Bioperfectus Technologies news releases